Rongrong Pan
Independent Non-Executive DirectorMs. Rongrong Pan had been Company Secretary at SciClone Pharmaceuticals (Holdings) Limited from March 2024 until October 2024 and served as its Joint Company Secretary since February 19, 2021 until March 2024. She had been Independent Non-Executive Director at Yidu Tech Inc. since January 15, 2021. She serves as Chief Financial Officer and serves as its Vice President since 2022 and also served as its Executive Director since May 25, 2023 at SciClone Pharmaceuticals (Holdings) Limited until October 2024. Ms. Pan has been the Chief Financial Officer and a Vice President of Finance at SciClone Pharmaceuticals Group since September 2018. Between July 2002 and November 2018, Ms. Pan worked at PricewaterhouseCoopers, Shanghai branch initially as an auditor; in July 2013, Ms. Pan became a partner of the audit practice of PricewaterhouseCoopers and held the position until she left PricewaterhouseCoopers in November 2018. Prior to Joining PricewaterhouseCoopers, Ms. Pan worked at Arthur Andersen as an associate of the audit group between August 2001 and June 2002. Ms. Pan was accredited as a member of the Chinese Institute of Certified Public Accountants in 2004. Ms. Pan received her master’s degree in accounting from Fudan University in July 2001 and her bachelor’s degree in international accounting from Shanghai International Studies University in July 1998.
Positions
- Company NameYidu Tech Inc.Stock Code02158PositionIndependent Non-Executive Director
